Ajooni Biotech Limited (IN:AJOONI)
:AJOONI
Want to see IN:AJOONI full AI Analyst Report?
AJOONI Stock Chart & Stats
₹5.13
₹0.07(0.90%)
At close: 4:00 PM EST
₹5.13
₹0.07(0.90%)
Day’s Range― - ―
52-Week Range₹3.55 - ₹6.60
Previous CloseN/A
Volume422.93K
Average Volume (3M)354.25K
Market Cap
N/A
Enterprise Value₹888.25M
Total Cash (Recent Filing)₹152.87M
Total Debt (Recent Filing)₹88.71M
Price to Earnings (P/E)17.6
Beta1.15
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.21
Shares Outstanding172,243,590
10 Day Avg. Volume263,831
30 Day Avg. Volume354,249
Financial Highlights & Ratios
PEG Ratio-0.85
Price to Book (P/B)2.02
Price to Sales (P/S)1.01
P/FCF Ratio-7.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained top-line acceleration (≈44% YoY in FY2026) indicates expanding product adoption and scale in animal health/nutrition. Durable revenue momentum supports market share gains, better supplier terms, and the potential to spread fixed costs over higher volumes, aiding long-term operating leverage.
Conservative LeverageLow debt-to-equity (~0.19) provides financial flexibility to fund working capital or capex without immediate refinancing pressure. A conservative capital structure reduces solvency risk and preserves optionality for strategic investments or M&A while cash conversion issues are addressed.
Defensible Business Model In Animal NutritionAjooni’s focus on consumable feed supplements and animal health addresses recurring demand in livestock/poultry farming. The product mix and distribution to farmers and distributors create repeat revenue potential and structural resilience tied to food-animal protein trends, supporting steady long-term demand.
Bears Say
Persistent Negative Operating Cash FlowFour straight years of negative operating cash flow mean reported profits are not converting to cash, raising funding and execution risk. Reliance on external financing or equity to bridge cash needs can dilute returns and limit the company’s ability to sustainably invest in growth or absorb shocks.
Thin And Eroding MarginsVery low and weakening margins constrain the firm’s capacity to self-finance growth and cushion input-cost volatility. Thin profitability reduces cash generation potential, increases sensitivity to price pressure, and limits the company’s ability to reinvest for scale or improve working capital dynamics.
Rising Debt Trend To MonitorAlthough absolute leverage remains modest, the recent uptick in debt combined with negative cash flows raises rollover and interest burden risk. If cash conversion does not improve, incremental debt could constrain liquidity and force costlier financing or asset sales to meet obligations.
Ajooni Biotech Limited News
AJOONI FAQ
What was Ajooni Biotech Limited’s price range in the past 12 months?
Ajooni Biotech Limited lowest stock price was ₹3.55 and its highest was ₹6.60 in the past 12 months.
What is Ajooni Biotech Limited’s market cap?
Currently, no data Available
When is Ajooni Biotech Limited’s upcoming earnings report date?
Ajooni Biotech Limited’s upcoming earnings report date is Jul 30, 2026 which is in 55 days.
How were Ajooni Biotech Limited’s earnings last quarter?
Ajooni Biotech Limited released its earnings results on May 28, 2026. The company reported ₹0.05 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.05.
Is Ajooni Biotech Limited overvalued?
According to Wall Street analysts Ajooni Biotech Limited’s price is currently Overvalued.
Does Ajooni Biotech Limited pay dividends?
Ajooni Biotech Limited does not currently pay dividends.
What is Ajooni Biotech Limited’s EPS estimate?
Ajooni Biotech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ajooni Biotech Limited have?
Ajooni Biotech Limited has 172,243,590 shares outstanding.
What happened to Ajooni Biotech Limited’s price movement after its last earnings report?
Ajooni Biotech Limited reported an EPS of ₹0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ajooni Biotech Limited?
Currently, no hedge funds are holding shares in IN:AJOONI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ajooni Biotech Limited
Ajooni Biotech Limited manufactures and sells animal feed in India. The company offers cattle feeds and feed supplements. Ajooni Biotech Limited was incorporated in 2010 and is based in Mohali, India.
Technical Analysis
Balaxi Pharmaceuticals Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
―
Lasa Supergenerics Ltd.
―
Vaishali Pharma Ltd.
―